|
Tue, 03/11/2025 - 14:05 |
Shrinking axonal spheroids may be a new approach for treating Alzheimer's disease. |
YaleUniversity |
|
Mon, 02/24/2025 - 04:45 |
Surgery May Improve Memory and Psychological Health for Chiari Malformation Patients, Pitt and UPMC Surgeons Report |
UPMC |
|
Wed, 01/15/2025 - 12:34 |
New Breakthrough Consortium for Olfactory Health offers Hope for the Many People Living with Smell Disorders |
Monell |
|
Thu, 08/08/2024 - 16:16 |
Faster in a dish model may speed up treatment for Parkinsons |
Harvard |
|
Thu, 07/11/2024 - 22:51 |
Expert alert: Procedure offers hope to patients living with physical changes from stroke, other conditions |
Mayo Clinic |
|
Thu, 05/16/2024 - 23:47 |
Scientists unravel genetic basis for neurodegenerative disorders that affect vision |
NIH |
|
Tue, 04/30/2024 - 20:45 |
Boosting the Fitness of Neurons Against Aging and Neurodegeneration |
dukepathdept |
|
Wed, 12/07/2022 - 19:25 |
Alnylam Submits Supplemental New Drug Application (sNDA) to U.S. Food and Drug Administration (FDA) for ONPATTRO (patisiran) for the Treatment of the Cardiomyopathy of ATTR Amyloidosis |
Alnylam |
|
Sun, 12/04/2022 - 19:47 |
Healey & AMG Center for ALS announces new drug regimen for testing DNL343 in HEALEY ALS Platform Trial |
Massachusetts G... |
|
Thu, 12/01/2022 - 12:05 |
Protein Mutation that Causes Parkinsons May Prevent Another Neurodegenerative Disease |
University of M... |
|
Wed, 11/16/2022 - 17:06 |
UTSW scientists identify brain circuit that triggers rare, blood sugar-dependent epilepsy |
UTSouthwestern |
|
Wed, 11/02/2022 - 14:43 |
Grant Will Support Amanda Woermans Innovative Gene Therapy Research into Treatment for Fatal Neurodegenerative Diseases |
University of M... |
|
Wed, 10/19/2022 - 15:00 |
Study Finds 'Probable Biologic and Genetic Overlap' Between Carpal Tunnel Syndrome and Migraine |
American Societ... |
|
Mon, 10/10/2022 - 07:25 |
Amwins Group Benefits Launches Gene Therapy Solutions Program Exclusively Available Through Stealth Partner Group |
AmWINS |
|
Fri, 09/30/2022 - 07:05 |
Scavenger cells in the nervous system linked to rare genetic disease |
Scripps Research |
|
Thu, 09/29/2022 - 19:11 |
HEALEY ALS Platform Trial |
Massachusetts G... |
|
Fri, 09/23/2022 - 15:00 |
Confronting the challenges of long COVID |
Harvard |
|
Tue, 09/20/2022 - 06:07 |
Alnylam Receives Approval in Europe for AMVUTTRA (vutrisiran) for the Treatment of Hereditary Transthyretin-mediated (hATTR) Amyloidosis in Adult Patients with Stage 1 or Stage 2 Polyneuropathy |
Alnylam |
|
Thu, 08/25/2022 - 03:49 |
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial for the Treatment of Patients with Multiple System Atrophy in Europe |
Alterity Therap... |
|
Thu, 08/18/2022 - 04:50 |
Alnylam to Present Data from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy at the 18th International Symposium on Amyloidosis |
Alnylam |
|
Fri, 07/22/2022 - 07:52 |
Researchers Learning More About the Neurological Effects of Long Covid |
IP Accuracy |
|
Tue, 07/12/2022 - 08:32 |
Investigational drug ABBV-CLS-7262 initiates design phase for entry into the HEALEY ALS Platform Trial |
Massachusetts G... |
|
Mon, 07/11/2022 - 13:32 |
Researchers Seeking Volunteers for a Study on Muscle Fatigue |
University of M... |
|
Wed, 07/06/2022 - 01:48 |
Alterity Therapeutics Doses First Patient in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy |
Alterity Therap... |
|
Thu, 06/30/2022 - 17:59 |
Alterity Therapeutics Receives U.S. FDA Approval for Investigational New Drug Application for ATH434 for the Treatment of Multiple System Atrophy |
Alterity Therap... |
